Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Elite Pharmaceuticals ( (ELTP) ) is now available.
Elite Pharmaceuticals has launched a generic version of Norco®, a prominent pain management drug, potentially tapping into a lucrative market with reported annual sales of $300 million. This move underscores Elite’s strategy to focus on niche generic products, leveraging its specialized manufacturing facilities in New Jersey to produce both immediate and controlled-release oral dose medications.
For a thorough assessment of ELTP stock, go to TipRanks’ Stock Analysis page.